Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.96+0.11 (+0.41%)
Close on Nov 18, 2026Market cap $3.53BP/E –Yield –
Surgery Partners r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Surgery Partners
Surgery Partners has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?